Surgical outcomes of robot-assisted super-low anterior resection or robot-assisted rectectomy with transanal anastomosis: a retrospective cohort study (ROSEMARY study)
Recruiting
- Conditions
- rectal cancer
- Registration Number
- jRCT1010220027
- Lead Sponsor
- Ichiro Takemasa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
- Patients who underwent R-sLAR or robot-assisted rectal resection with transanal anastomosis (R-ISR or R-TaTME) between January 1, 2020 and December 31, 2021
- Patients histologically diagnosed with rectal cancer (pap, tub, por, muc, sig, med, or asc)
Exclusion Criteria
- Patients who indicated their intention to refuse to use the data for this study
- Other patients who are judged to be inappropriate by the principal investigator or co-investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of robot-assisted super-low anterior resection in rectal cancer?
How does robot-assisted transanal anastomosis compare to traditional laparoscopic rectal resection in oncologic outcomes?
Which biomarkers are associated with favorable outcomes in rectal cancer patients undergoing robotic surgery?
What are the potential adverse events and management strategies for robotic rectal resection techniques?
Are there combination approaches involving robotic surgery and neoadjuvant therapies for rectal cancer?